Username:
Password:
Enter your email below to subscribe to our Health & Biotech News Digest.
Search:
From:
To:

News Digest Archive

Search:
From:
To:
Aug 23, 2010
Two-Year Data from Phase 2 Trial of Genzyme's Eliglustat Tartrate for Gaucher Disease To Be Published in the Journal Blood
CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Genzyme Corporation (NASDAQ: GENZ - News) announced today that the two-year follow-up results from the phase 2 clinical trial of its investigational therapy known as eliglustat tartrate have been accepted for publication in the journal Blood. The re Read More...
Source: Yahoo Biotech News



Aug 23, 2010
Alnylam and Collaborators Publish New Pre-clinical Research on Therapeutic Silencing of Parkinson's Disease Gene
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY - News), a leading RNAi therapeutics company, and collaborators at The Parkinson’s Institute and the Mayo Clinic have published new research findings in the journal Public Library of Science (PLoS). The Read More...
Source: Yahoo Biotech News



Aug 23, 2010
Celgene's Revlimid Marches on -
(NasdaqGS: CELG - News) received a boost with its lead product Revlimid gaining approval in Japan for the treatment of deletion 5q myelodysplastic syndromes (MDS). The approval comes close on the heels of the drug receiving Japanese approval in combination with dexamethasone for treating patie Read More...
Source: Yahoo Biotech News



Aug 23, 2010
Epilepsy Organizations Award Grants for New Gene Therapy to Treat Epilepsy and ...
MIDDLEBURG, Va., , Aug. 23 /PRNewswire-USNewswire/ -- The Epilepsy Therapy Project (ETP) and the Epilepsy Foundation (EF) today announced the latest grant recipients of its New Therapy Grants Program, a unique joint venture of the non-profit epilepsy organizations, to advance promising epil Read More...
Source: Google Health News



Aug 23, 2010
HIV-resistant cells work in mice. Can they help humans?
Clad in a yellow gown, blue foot covers, hair net, face mask and latex gloves, Paula Cannon pushed open the door to the animal room. "I hate this smell," she said, wrinkling her nose.     The stink came from scores of little white mice scurrying about in cages. Some of the ca Read More...
Source: Google Health News



Aug 23, 2010
Tufts researchers find key to treating eye diseases
Scientists at Tufts University School of Medicine and the Sackler School of Graduate Biomedical Sciences at Tufts have demonstrated non-viral gene therapy that may delay degenerative eye disorders. The research was conducted in a study to be published in Molecular Therapy. The gene therapy relies Read More...
Source: Google Health News



Aug 23, 2010
The Next Big Thing: Developing The Artificial Pancreas For People With Diabetes
All people with type 1 diabetes, and some with type 2, need to inject or pump insulin into their bodies to survive. Figuring out how much insulin is necessary requires frequent monitoring and can be difficult, even risky. According to Diabetes Forecast, the consumer magazine of the American Diabetes Read More...
Source: Medical News Today



Aug 23, 2010
Review Of New Countermeasures For Bioterror And Pandemic Threats - Initial $2 Billion Investment, USA
Kathleen Sebelius, US Department of Health and Human Services (HSS) Secretary, says that the USA needs to have a system that is nimble and flexible enough to rapidly produce medical countermeasures in the face of known or unexpected attacks or threats. Medical countermeasures refers to a government Read More...
Source: Medical News Today



Aug 23, 2010
A Cure For HIV Could Be All In The 'Mix'
Current HIV treatments do not eradicate HIV from host cells but rather inhibit virus replication and delay the onset of AIDS. However, a new research published in BioMed Central's open access journal, AIDS Research & Therapy describes an innovative approach to eliminate HIV in host by targeted k Read More...
Source: Medical News Today



Aug 23, 2010
A 'Kill Switch' for Rogue Microbes
Biologists often speak of switching genes on and off to give microbes new abilities--like producing biofuels or drugs, or gobbling up environmental toxins. For the most part, though, it's nearly impossible to turn off a gene without deleting it (which means you can't turn it on again). This limi Read More...
Source: MIT's Technology Review



7293 results:

<<123456...730>>


© 2007 GBP Capital. All Rights Reserved. Legal | Privacy Statement | Sitemap